ARCHIVES

Richard Klausner resigned from the Gates Foundation, saying move was unrelated to Congressional investigation of NCI contract to Harvard University during Klausner’s tenure as NCI director.

This article is from The Cancer Letter archive.

Vol. 31 No. 33 | September 16, 2005

Download PDF Visit The Full Archive

Related Articles

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

February 20, 1981

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Congress Passes HHS Appropriations, Includes $9 Billion for NIH, $575 Million Delayed Funding

November 15, 1991

Boyd Steps Down As DTP Director, Returns to Research

February 16, 1990

ASPO Hears Proposals For Economic Attacks On Tobacco Industry

April 7, 1989